Log in
Log into your PedsMrkt account to access our Community forums.
If you don't see an email, please check your Junk folder. The email will be sent from support@pedsmrkt.com
Log into your PedsMrkt account to access our Community forums.
If you don't see an email, please check your Junk folder. The email will be sent from support@pedsmrkt.com
Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions.
Ceribell has developed the Ceribell System, a novel electroencephalography (“EEG”) platform specifically designed to address the unmet needs of preterm neonates through adults in the acute-care setting. By combining proprietary, highly portable, and rapidly deployable hardware with its artificial intelligence (“AI”)-powered Clarity® algorithm, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
Ceribell’s Clarity algorithm is FDA 510(k) cleared for indicating suspected seizure activity and, as part of the Ceribell System, is utilized in ICUs, NICUs, PICUs, and emergency rooms across the U.S. For more information, visit www.ceribell.com.
Ceribell’s industry-leading Rapid EEG system was originally engineered to redefine seizure detection and management in adults. By combining highly portable hardware with its Clarity® AI-powered algorithm, Ceribell enables rapid, bedside diagnosis where traditional EEG access may fall short.
For neonate and pediatric patients, care may be delayed because EEG is simply not available. In the developing brain, diagnostic and treatment delays can have long-term neurocognitive impact. That’s why Ceribell committed years of specialized development to bridge the gap for these vulnerable patients.
Optimizing Your Hospital’s Neonatal and Pediatric EEG Program
Through dedicated R&D, Ceribell became the first and only provider of an FDA-cleared seizure detection algorithm for pre-term neonates through adults enabling rapid bedside detection, diagnosis, and treatment of non-convulsive seizures. Ceribell provides a comprehensive ecosystem, enabling hospitals to efficiently offer a complete EEG program to continuously monitor patients in acute-care settings.:
Rapid, Gentle EEG Placement
Precision Monitoring
Expert Interpretation
By addressing the unique physiological needs of neonatal and pediatric patients, Ceribell is fulfilling its mission to establish a new standard of care in the acute-care setting—helping clinicians save lives through immediate, actionable brain health insights.
*Note: Tele-EEG services are available in select states.
How do you treat a seizure with no outward signs? For one three-and-a-half-year-old, traditional diagnostics weren't enough. Despite a history of staring episodes, both a routine EEG and a three-day home study were normal.
Everything changed in the emergency department (ED) with Ceribell Point-of-Care (POC) EEG.
The Breakthrough:
· Non-Convulsive Seizure Detection: 40 minutes into the recording, the EEG detected focal non-convulsive seizures.
· Silent Symptoms: The seizures occurred while the patient was sleeping in their mother's arms, showing no overt clinical signs.
· Rapid Resolution: Immediate administration of lorazepam and valproate sodium resolved the seizures.
The Result:
With the rapid, critical diagnostic support of the Ceribell POC EEG, the young patient is now seizure-free on medication.
This case demonstrates the vital importance of accessible, continuous EEG monitoring in the ED to capture what routine 20-minute studies often miss.
--- Download the full case study to see the clinical details.
#ChildNeurology #PedNeuro #Ceribell
CAUTION: Device does not substitute for EEG review by a qualified clinician. Before use, review the manual for indications, contraindications, warnings, precautions, potential adverse events, and Instructions for Use. Sale requires the order of a physician.